Cargando…

The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair

OBJECTIVE: This study aims to explore the role of MARK2 in chemotherapeutic resistance and potential mechanism within cisplatin resistance models of CD133(+) MG-63 and MNNG/HOS cells. METHODS: CD133(−) and CD133(+) MG-63 and MNNG/HOS cells were differentiated and obtained by MACS(Magnetic bead sorti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Liang, Sun, Zhengkao, Wei, Xianfu, Tan, Hongdong, Kong, Peng, Li, Zhenfeng, Yang, Qiang, Dai, E'nuo, Li, Jianmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184251/ https://www.ncbi.nlm.nih.gov/pubmed/32368441 http://dx.doi.org/10.1016/j.jbo.2020.100290

Ejemplares similares

GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma
por: Xie, Chaofan, et al.
Publicado: (2021)

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022)

Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma
por: Jeddo, Salim F.A., et al.
Publicado: (2020)

Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells
por: Zhang, Zhengpei, et al.
Publicado: (2017)

ITGB3 promotes cisplatin resistance in osteosarcoma tumors
por: Li, Qian, et al.
Publicado: (2023)

Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
por: Li, Hong-Bo, et al.
Publicado: (2021)

Identification of genes contributing to cisplatin resistance in osteosarcoma cells
por: Xie, Mingzhong, et al.
Publicado: (2022)

Interferon-α suppresses invasion and enhances cisplatin-mediated apoptosis and autophagy in human osteosarcoma cells
por: ZHAO, JUN, et al.
Publicado: (2014)

Clonal dynamics in osteosarcoma defined by RGB marking
por: Gambera, Stefano, et al.
Publicado: (2018)

HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: A systematic review and meta-analysis of 16 studies
por: Zhang, Qingyu, et al.
Publicado: (2016)

Circular RNA expression pattern in cisplatin-resistant osteosarcoma cells
por: Han, Jianhua, et al.
Publicado: (2020)

Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma
por: Zhang, Zhongkai, et al.
Publicado: (2020)

Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway
por: Liu, Bin, et al.
Publicado: (2018)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

Inhibition of TREM-2 Markedly Suppresses Joint Inflammation and Damage in Experimental Arthritis
por: Sigalov, Alexander B.
Publicado: (2022)

Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro.
por: Dabholkar, M, et al.
Publicado: (1992)

p53 inhibits CTR1-mediated cisplatin absorption by suppressing SP1 nuclear translocation in osteosarcoma
por: Yong, Lei, et al.
Publicado: (2023)

Nucleotide excision repair leaves a mark on chromatin: DNA damage detection in nucleosomes
por: Apelt, Katja, et al.
Publicado: (2021)

Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling
por: Yu, Ling, et al.
Publicado: (2016)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells
por: Sun, Xilong, et al.
Publicado: (2017)

Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments
por: Fanelli, Marilù, et al.
Publicado: (2020)

HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repair
por: Zhou, Ting, et al.
Publicado: (2019)

DNA Damage Response Genes in Osteosarcoma
por: Tang, Ying, et al.
Publicado: (2021)

Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin
por: Liu, Qing, et al.
Publicado: (2020)

Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway
por: Jin, Wangdong, et al.
Publicado: (2018)

Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment
por: Zhang, Guoyou, et al.
Publicado: (2011)

TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production
por: Han, Xiu-guo, et al.
Publicado: (2018)

Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma
por: Liu, Yufeng, et al.
Publicado: (2020)

MicroRNA-584 Impairs Cellular Proliferation and Sensitizes Osteosarcoma Cells to Cisplatin and Taxanes by Targeting CCN2
por: Li, Li, et al.
Publicado: (2020)

MicroRNA Involvement in Osteosarcoma
por: Kobayashi, Eisuke, et al.
Publicado: (2012)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin
por: Cenni, B, et al.
Publicado: (1999)

CD271(+) Osteosarcoma Cells Display Stem-Like Properties
por: Tian, Jiguang, et al.
Publicado: (2014)

Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins
por: Li, Kexin, et al.
Publicado: (2023)

RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro
por: SI, HAIPENG, et al.
Publicado: (2011)

Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma
por: Li, Xiaoyang, et al.
Publicado: (2020)

Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma
por: Zhong, Binlong, et al.
Publicado: (2019)

The synergistic antitumor effect of cinobufagin and cisplatin in human osteosarcoma cell line in vitro and in vivo
por: Dai, Guo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n6vkca10i54psm8ntu7ij6kqkc